Fairvalue-Calculator Fairvalue-Calculator
EN DE

Apyx Medical Corporation (APYX) Fair Value & Analysis

Healthcare · US · Market cap $176M

Price$4.08
Fair Value$1.56
Upside-61.8%
Quality95/100
Evidence: Low Range $1.17 – $1.95

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Apyx Medical Corporation (APYX) currently trades at $4.08, while our model-based Fair Value estimate is $1.56 — implying the stock looks roughly 61.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated …

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Apyx Medical Corporation (APYX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $1.56 versus a price of $4.08 — about −62% (overvalued). Model-based estimate, not financial advice.
What is the fair value of APYX?
Our 21-model fair value for Apyx Medical Corporation is $1.56 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.08.
What is the quality score of APYX?
Apyx Medical Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.